Intravenous estrogens increase insulin clearance and action in postmenopausal women

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 2 48-2, 2003, Pages

  Van Pelt, R E ^a,b   Gozansky, W S ^a   Schwartz, R S ^a   Kohrt, W M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Box B179 ^*  (United States)

Author keywords

Conjugated estrogens; Euglycemic clamp; Lipolysis

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; GLUCOSE; GLYCEROL; INSULIN;

ADULT; ARTICLE; BODY COMPOSITION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG MECHANISM; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GLUCOSE INFUSION; GLYCEROL BLOOD LEVEL; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPERINSULINISM; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; LIPOLYSIS; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; STEADY STATE; TIME SERIES ANALYSIS;

EID: 0042804807     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00490.2002     Document Type: Article

References (47)

1. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, and Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J Investig Med 49: 119-126, 2001.
2. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 13: 795-803, 1997.
3. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, and Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40: 843-849, 1997.
4. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, and Melis GB. Effects of low doses of transdermal 17-β estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74: 1396-1400, 1992.
5. Campbell SE and Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 282: E1139-E1146, 2002.
6. Cefalu WT, Wagner JD, Bell-Farrow AD, Wang ZQ, Adams MR, Toffolo G, and Cobelli C. The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). Am J Obstet Gynecol 171: 440-445, 1994.
7. Cheung AP. Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. Maturitas 35: 45-50, 2000.
8. Colacurci N, Zarcone R, Mollo A, Russo G, Passaro M, de Seta L, and de Franciscis P. Effects of hormone replacement therapy on glucose metabolism. Panminerva Med 40: 18-21, 1998.
9. Crook D, Godsland IF, Hull J, and Stevenson JC. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow-up. Br J Obstet Gynaecol 104: 298-304, 1997.
10. Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, and Lanzone A. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140: 215-223, 1999.
11. Cucinelli F, Soranna L, Romualdi D, Musj G, Mancuso S, and Lanzone A. The effect of raloxifene on glyco-insulinemic homeostasis in healthy postmenopausal women: a randomized placebo-controlled study. J Clin Endocrinol Metab 87: 4186-4192, 2002.
12. DeFronzo RA, Tobin JD, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
13. Després JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9: 452-459, 1993.
14. Dos Santos EG, Dieudonne MN, Pecquery R, Le M, Giudicelli VY, and Lacasa D. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143: 930-940, 2002.
15. Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JM, and Lumsden MA. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 84: 2402-2407, 1999.
16. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, and Bush TL. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI investigators Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 21: 1589-1595, 1998.
17. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, and Greenfield M. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 82: 1549-1556, 1997.
18. Evans EM, Van Pelt RE, Binder EF, Williams DB, Ehsani AA, and Kohrt WM. Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women. J Appl Physiol 90: 2033-2040, 2001.
19. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, and Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82: 414-417, 1997.
20. Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, and Stevenson JC. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42: 846-853, 1993.
21. Gonzalez C, Alonso A, Grueso NA, Diaz F, Esteban MM, Fernandez S, and Patterson AM. Effect of treatment with different doses of 17-beta-estradiol on insulin receptor substrate-1. J Physiol 2: 140-149, 2001.
22. Gonzalez C, Alonso A, Grueso NA, Esteban MM, Fernandez S, and Patterson AM. Effect of treatment with different doses of 17-beta-estradiol on the insulin receptor. Life Sci 70: 1621-1630, 2002.
23. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, and Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97: 12729-12734, 2000.
24. Hollingsworth DR. Alterations of maternal metabolism in normal and diabetic pregnancies: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Am J Obstet Gynecol 146: 417-429, 1983.
25. Iozzo P, Pratipanawatr T, Pijl H, Vogt C, Kumar V, Pipek R, Matsuda M, Mandarino LJ, Cusi KJ, and DeFronzo RA. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. Am J Physiol Endocrinol Metab 280: E712-E719, 2001.
26. Jensen MD, Martin ML, Cryer PE, and Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol Endocrinol Metab 266: E914-E920, 1994.
27. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, and Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138: 1-9, 2003.
28. Katz H, Butler P, Homan M, Zerman A, Caumo A, Cobelli C, and Rizza RA. Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error. Am J Physiol Endocrinol Metab 264: E561-E566, 1993.
29. Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, and Berger M. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 6: 36-42, 1999.
30. Koopmans SJ, Kushwaha RS, and DeFronzo RA. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases do novo lipogenesis but does not cause dyslipidemia in conscious normal rats. Metabolism 48: 330-337, 1999.
31. Kumagai S, Holmang A, and Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149: 91-97, 1993.
32. Lindheim SR, Duffy DM, Kojima T, Vijod MA, Stanczyk FZ, and Lobo RA. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 62: 1176-1180, 1994.
33. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, and Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60: 664-667, 1993.
34. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, and MacDonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulaemic euglycaemia and hypoglycaemia. Diabetologia 35: 287-290, 1992.
35. Livingstone C and Collison M. Sex steroids and insulin resistance. Clin Sci (Colch) 102: 151-166, 2002.
36. Lobo RA, Pickar JH, Wild RA, Walsh BW, and Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 84: 987-995, 1994.
37. Mittendorfer B, Horowitz JF, and Klein S. Gender differences in lipid and glucose kinetics during short-term fasting. Am J Physiol Endocrinol Metab 281: E1333-E1339, 2001.
38. O'Sullivan AJ and Ho KKY. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80: 1783-1788, 1995.
39. Pedersen SB, Borglum JD, Moller-Pedersen T, and Richelsen B. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol 85: 13-19, 1992.
40. Poehlman ET, Toth MJ, and Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123: 673-675, 1995.
41. Pulido JME and Salazar MA. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 30: 19-22, 1999.
42. Ryan AS, Nicklas BJ, and Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25: 127-133, 2002.
43. Saglam K, Polat Z, Yilmaz MI, Gulec M, and Akinci SB. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 18: 211-214, 2002.
44. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, and Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331: 1056-1061, 1994.
45. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead M, and Stevenson JC. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism 49: 742-747, 2000.
46. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, and Kohrt WM. Waist circumference vs. body mass index for prediction of disease risk in postmenopausal women. Int J Obes Relat Metab Disord 25: 1183-1188, 2001.
47. Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA, and Cefalu WT. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab 83: 896-901, 1998.